|
- Home | Optune® for Glioblastoma
Optune is a wearable, portable, FDA-approved glioblastoma (GBM) treatment for adult patients aged 22 years or older It works by creating Tumor Treating Fields (TTFields), which are electric fields that slow down or stop GBM cancer cell division
- Find a Treatment Center | Optune® for Healthcare Professionals
Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy
- Find a Treatment Center | Optune® for Healthcare Professionals
Optune with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery, and completion of radiation therapy together with concomitant standard of care chemotherapy
- INSTRUCTIONS FOR USE - Optune
Optune® with temozolomide is indicated for the treatment of adult patients with newly diagnosed, supratentorial glioblastoma following maximal debulking surgery and completion of radiation therapy together with concomitant standard of care chemotherapy
|
|
|